Lucas Lopes | Medicina | Best Researcher Award

Published on by Neuroscientists

Mr. Lucas Lopes | Medicina | Best Researcher Award

Mr. Lucas Lopes, Universidade de São Paulo, Faculdade de Medicina de Bauru,  Brazil.

Lucas Casagrande Passoni Lopes has made significant strides in medical research, academic publishing, and global scientific collaboration. His expertise in pediatric medicine, endocrinology, and healthcare disparities has been widely recognized through his editorial leadership, peer-review contributions, and multilingual engagements. His published works address critical healthcare issues, further cementing his influence in the medical community.

Profile

Orcid

🎓 Early Academic Pursuits

Lucas Casagrande Passoni Lopes embarked on his academic journey with an unwavering passion for medicine, enrolling in the prestigious Faculdade de Medicina de Bauru at the Universidade de São Paulo, Brazil. His commitment to excellence and keen interest in pediatric and clinical research set the foundation for his future endeavors. Throughout his academic years, he demonstrated exceptional dedication, immersing himself in scientific studies and medical advancements, laying the groundwork for a promising career in healthcare and medical research.

👩‍🎓 Professional Endeavors

Beyond his medical studies, Lucas took on significant roles in the academic publishing landscape. As the In-Chief Editor of Advances in Modern Paediatrics Journal, he has played a pivotal role in shaping pediatric research dissemination. His editorial contributions extend to renowned medical journals, including Journal of Anaesthesia and Global Open Share Publishing, Clinics of Neurology, Annals of Pediatrics and Neonatal Care, and the European Journal of Cancer. Through his editorial expertise, he has facilitated the publication of groundbreaking research, furthering advancements in multiple medical disciplines.

🔬 Contributions and Research Focus

Lucas has established himself as a prolific researcher, focusing on pediatric medicine, endocrinology, and public health concerns. His notable studies include an in-depth analysis of treatments for dysmenorrhea in adolescents, published in Contemporânea – Revista de Ética e Filosofia Política, and a groundbreaking study on the underreporting of diabetes mellitus as a cause of death over 40 years in Bauru, published in Archives of Endocrinology and Metabolism. His work sheds light on critical gaps in healthcare reporting and patient management, making substantial contributions to medical literature and clinical practice.

🏆 Accolades and Recognition

Lucas’ dedication to medical research has earned him esteemed recognition within the scientific community. As an invited reviewer for numerous high-impact journals, including Current Pediatric Reviews, World Journal of Clinical Cases, International Journal of Clinical and Experimental Medical Sciences, World Journal of Gastroenterology, and Frontiers in Medicine, he has been entrusted with evaluating and shaping contemporary medical research. His expertise is widely acknowledged, with his insights influencing the peer-review process across various fields of medicine.

📚 Impact and Influence

Lucas’ influence extends far beyond his research and editorial roles. His multilingual proficiency in Portuguese, English, French, Italian, Spanish, and German allows him to engage with diverse international scientific communities, fostering cross-border collaborations. His involvement in global medical discourse ensures that cutting-edge research reaches a broader audience, ultimately contributing to the improvement of healthcare systems worldwide. His mentorship and editorial leadership have guided emerging researchers, amplifying the impact of his contributions to medical academia.

🌟 Legacy and Future Contributions

With a strong foundation in medical research and editorial expertise, Lucas continues to shape the future of pediatric and clinical medicine. His ongoing commitment to identifying healthcare disparities, advancing treatment methodologies, and supporting evidence-based medical practices positions him as a key figure in modern medical research. As he forges ahead, his contributions promise to enhance patient care, influence policy reforms, and inspire future generations of medical professionals. His legacy in scientific inquiry and knowledge dissemination will undoubtedly leave a lasting mark on the field of medicine.

 

publication

  • Title: Association between exanthematous diseases and earlier age at Type 1 diabetes diagnosis
    Authors: Lucas C.P. Lopes, Lenita Zajdenverg, Rodrigo L.M. Martins, Gabriel Araujo Medeiros, Marina D. Louro, João V.M. Lanzarin, Carlos A. Negrato
    Year: 2025

 

  • Title: Mortality trends from all causes and diabetes mellitus according to sex between 1998 and 2021
    Authors: Carlos Antonio Negrato, Gabriel Araújo Medeiros, Giordano Bruno Duarte de Souza, Lucas Casagrande Passoni Lopes
    Year: 2024

 

  • Title: Relationship between early age at menarche, older age at menopause and subtypes of breast cancer: a scoping review
    Authors: Lucas Casagrande Passoni Lopes, Gabriel Araújo Medeiros, Igor José Nogueira Gualberto, Thales Baptista Gut, Rafael Vasconcelos Silva Ferrazini, Carlos Antonio Negrato
    Year: 2024

 

  • Title: Association between perinatal and obstetric factors and early age at diagnosis of type 1 diabetes mellitus: a cohort study
    Authors: Carlos A. Negrato, Rodrigo L. de M. Martins, Marina D. Louro, Gabriel A. Medeiros, João V.M. Lanzarin, Lenita Zajdenverg, Lucas C.P. Lopes
    Year: 2024

 

  • Title: Underreporting of diabetes mellitus as the cause of death in Bauru, State of São Paulo, Brazil over 40 years: a documental study
    Authors: Lucas Casagrande Passoni Lopes, Gabriel Araújo Medeiros, Mauro Wieczorek, Marina dos Santos de Carvalho Pinto, Carlos Antonio Negrato
    Year: 2024

 

🎉 Conclusion

As a dedicated researcher, editor, and medical professional, Lucas Passoni continues to push the boundaries of medical knowledge and patient care. His contributions have not only enriched scientific literature but have also fostered meaningful discussions on global healthcare improvements. With his unwavering commitment to excellence, Lucas is poised to leave a lasting legacy in the field of medicine, inspiring future generations of researchers and practitioners alike.

 

 

Zewen Cheng | Clinical Medicine | Young Scientist Award

Published on by Neuroscientists

Dr. Zewen Cheng | Clinical Medicine | Young Scientist Award

Dr. Zewen Cheng, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine,  China.

Zewen Cheng’s career is a testament to his dedication to thoracic surgery, combining expertise in both Western and Traditional Chinese medicine. His academic excellence, professional experience, and research contributions highlight his unwavering commitment to advancing patient care. As a skilled surgeon and educator, he continues to make a significant impact in the medical community. Moving forward, his focus on innovation and mentorship will ensure that his contributions leave a lasting mark on the field of thoracic surgery, inspiring future generations of medical professionals.

Profile

Scopus

 

🎓 Early Academic Pursuits

Zewen Cheng embarked on his medical journey with a passion for thoracic surgery, earning a Master of Medicine in Thoracic Surgery from Soochow University in Suzhou, China. Graduating in 2019, he dedicated himself to mastering the complexities of thoracic diseases, developing a strong foundation in both clinical and surgical practices. His academic years were marked by rigorous training and an unwavering commitment to patient care, setting the stage for his future contributions to the medical field.

🏥 Professional Endeavors

After completing his degree, Zewen Cheng undertook a comprehensive three-year residency at The First Affiliated Hospital of Soochow University. From July 2019 to June 2022, he refined his expertise in thoracic surgery, gaining invaluable hands-on experience in clinical diagnostics, patient management, and surgical procedures. His tenure in the residency program enabled him to work closely with senior specialists, tackling complex cases and honing his skills. In September 2022, he advanced to the role of Attending Physician at Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, where he seamlessly integrates Western and Traditional Chinese medical treatments to provide holistic patient care.

🔬 Contributions and Research Focus

Zewen Cheng is deeply invested in the evolving landscape of thoracic surgery. His research interests span innovative surgical techniques, minimally invasive procedures, and the integration of Traditional Chinese Medicine (TCM) in thoracic disease management. With proficiency in data analysis software such as R and SPSS, he actively contributes to medical research, utilizing statistical methodologies to enhance clinical decision-making. His work emphasizes the importance of interdisciplinary approaches in improving patient outcomes and advancing the field of thoracic surgery.

🏆 Accolades and Recognition

Throughout his medical career, Zewen Cheng has been recognized for his dedication and expertise in thoracic surgery. Successfully completing the standardized residency training at The First Affiliated Hospital of Soochow University, he demonstrated exceptional skill and commitment to surgical excellence. His fluency in Medical English (CET-6) has enabled him to collaborate effectively with international medical professionals, further expanding his impact within the global medical community.

💪 Impact and Influence

As an Attending Physician, Zewen Cheng plays a crucial role in supervising and training junior doctors, fostering the next generation of thoracic surgeons. His ability to blend traditional and modern medical practices ensures that patients receive comprehensive treatment tailored to their specific needs. His contributions extend beyond direct patient care, as he actively participates in multidisciplinary teams, shaping the future of thoracic surgery through collaborative innovation and knowledge sharing.

🌟 Legacy and Future Contributions

With a strong foundation in both clinical practice and research, Zewen Cheng aspires to push the boundaries of thoracic surgery through continuous learning and innovation. His commitment to integrating Traditional Chinese Medicine with contemporary surgical techniques presents new avenues for patient care and treatment efficacy. Looking ahead, he envisions contributing to groundbreaking research, refining surgical methodologies, and mentoring future medical professionals, leaving a lasting legacy in the field of thoracic surgery.

 

Publication

Title: Exploring the Causal Relationship Between Frailty and Chronic Obstructive Pulmonary Disease: Insights From Bidirectional Mendelian Randomization and Mediation Analysis
Authors: Zewen Cheng, Jian Wu, Chun Xu, Xiaokun Yan
Year: 2025

 

🏆 Conclusion

Zewen Cheng is a strong candidate for the Young Scientist Award, given his clinical expertise, innovative approach to medicine, and commitment to training future surgeons. Strengthening his research impact and expanding international collaborations would further solidify his position as a leading young scientist in thoracic surgery.

 

 

Dinh Phong Son | CircRNA | Best Researcher Award

Published on by Neuroscientists

Dr. Dinh Phong Son | CircRNA | Best Researcher Award

Dr. DINH PHONG SON, DUYTAN UNIVERSITY, Vietnam.

Dr. Dinh Phong Son is a researcher specializing in laboratory medicine techniques with a Ph.D. in Molecular Medicine from Guangxi Medical University, China. His research focuses on modern molecular biology techniques, particularly the identification of potential biomarkers for early disease diagnosis and targeted therapy. His studies explore systemic diseases such as diabetes, cardiovascular diseases, and cancer, emphasizing gene editing technologies like CRISPR/Cas9. His recent publications contribute to the understanding of regulatory RNA networks and their implications in disease mechanisms, providing a foundation for future studies on molecular interactions and targeted drug development.

Profile

Orcid

 

🎓 Early Academic Pursuits

From the very beginning of my academic journey, I was deeply fascinated by the intricate mechanisms of life at a molecular level. My pursuit of knowledge led me to study Laboratory Medicine Technique at Hue University of Medicine and Pharmacy, Vietnam, where I honed my expertise in diagnostic methodologies and medical laboratory sciences. With an insatiable thirst for discovery, I furthered my education by earning a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China. This academic foundation set the stage for my dedication to the field of molecular biology, shaping my vision to explore genetic markers and innovative diagnostic tools.

👩‍🎓 Professional Endeavors

Currently, I serve at Duy Tan University, College of Medicine and Pharmacy, where I actively contribute to research, mentoring, and academic discourse. My work primarily revolves around molecular diagnostics, genetic analysis, and disease biomarker identification, aiming to bridge the gap between molecular biology and clinical applications. With advancements in next-generation sequencing (NGS) and bioinformatics databases, I continually seek new pathways to enhance the precision of disease detection and treatment strategies.

🧪 Contributions and Research Focus

My research is deeply rooted in molecular medicine, focusing on the identification of potential biomarkers for the early diagnosis of systemic diseases such as diabetes, cardiovascular diseases, stroke, and cancer. My investigations also extend to exploring gene targets for pharmacological studies, assisting in drug development through the modulation of gene expression using cutting-edge technologies like CRISPR/Cas9, gene overexpression, and silencing approaches. Furthermore, my work delves into the complex LncRNA/CircRNA/miRNA/gene/protein-drug interaction networks, paving the way for theoretical models that could revolutionize targeted therapy research.

 

💎 Impact and Influence

The impact of my research extends beyond academia, as it plays a crucial role in early disease screening, personalized medicine, and therapeutic advancements. By leveraging molecular networks, I aim to facilitate the development of precise diagnostic tools and gene-targeted interventions, significantly improving patient outcomes. My research findings have the potential to reshape biomedical applications and create avenues for innovative treatment strategies across various diseases.

🌟 Legacy and Future Contributions

Looking ahead, my aspirations remain steadfast in expanding molecular biology research, particularly in uncovering novel biomarkers and refining gene-editing techniques. As the field continues to evolve, I hope to contribute to the refinement of therapeutic gene modifications and biomarker-based diagnostics. With sustained efforts and collaborations, I envision a future where my research serves as a cornerstone for breakthroughs in precision medicine, targeted gene therapy, and advanced molecular diagnostics.

👨‍💼 Professional Collaborations and Memberships

As an active member of the scientific community, I engage in collaborations and professional affiliations to foster knowledge exchange and multidisciplinary research. My involvement in editorial appointments, consultancy projects, and industry partnerships enables me to extend my research impact, ensuring that molecular medicine continues to advance for the benefit of humanity.

 

Publication

  • Title: Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on Microarray Data analysis, molecular docking, and dynamic simulation
    Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Hai-Anh Ha, Aigul Utegenova, Awais Ali, Abdulaziz Alamri
    Year: 2025

 

  • Title: Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1
    Authors: PhongSon Dinh, ChauMyThanh Tran, ThiPhuongHoai Dinh, Awais Ali, ShangLing Pan
    Year: 2024

 

  • Title: Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data
    Authors: ChauMyThanh Tran, PhongSon Dinh
    Year: 2024

 

  • Title: Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease
    Authors: PhongSon Dinh, JunHua Peng, ThanhLoan Tran, DongFeng Wu, ChauMyThanh Tran, ThiPhuongHoai Dinh, ShangLing Pan
    Year: 2023

 

  • Title: Construction of miRNAs and gene expression profiles associated with ischemic cardiomyopathy: Bioinformatics analysis
    Authors: PhongSon Dinh, Jun-Hua Peng, ChauMyThanh Tran, ThanhLoan Tran, Shang-Ling Pan
    Year: 2022

 

Conclusion

Dr. Son’s research plays a crucial role in advancing molecular biology by identifying key biomarkers and regulatory networks for disease screening and treatment. His work in gene-targeted therapy and RNA interaction networks lays the groundwork for future innovations in precision medicine. Despite challenges in resources and time, his commitment to molecular research aims to drive further advancements in understanding and treating complex diseases.

Shahar Shelly | Epidemiology | Best Researcher Award

Published on by Neuroscientists

Dr. Shahar Shelly | Epidemiology | Best Researcher Award

Dr. Shahar Shelly,  Rambam Medical Center, Israel.

Dr. Shahar Shelly, MD, is a globally recognized neurologist and researcher specializing in neuroimmunology and neuromuscular disorders. With academic roles across Rambam Medical Center, Technion Institute, and the Mayo Clinic, Dr. Shelly has driven advancements in clinical diagnostics, treatment strategies, and disease understanding.

 

profile

Scholor

🎓 Education

University Medical School of Hungary, Debrecen – Summa Cum Laude (01/2005–01/2012). Shamir Medical Center, Zerifin, Israel – Internship (Cum Laude) (01/2012–01/2013). Sheba Medical Center – Residency, Neurology Department (01/2013–01/2017). Mayo Clinic, Rochester, MN – Neuroimmunology Fellowship (04/2018–07/2019). Neuromuscular Disorders, Muscle Fellowship – Mayo Clinic (07/2019–07/2020) Neuromuscular Disorders, Nerve Fellowship – Mayo Clinic (07/2020–07/2021).

📜 Certifications

Israeli Neurology Board Certification (2018). Educational Commission for Foreign Medical Graduates (ECFMG) (2018). Mayo Clinic Quality Fellow Certification (2019). Medical Genetics Certificate – Recanti Genetic Institute (2015). Advanced Electrophysiology Certification – Board-Licensed Electromyography (2019).

🏆 Honors & Awards

Summa Cum Laude – University Medical School of Hungary.  Cum Laude – Hassaf Harofeh Medical Center Internship.Israel Medical Association Fellowship Award (2017). Best Abstract Award – American Academy of Neurology (2019).

🔬 Patents & Innovations

Digital Drug Amplifier – Combines digital therapeutics with pharmaceuticals (FDA-approved). IMNM Muscle Disease Screening Software – Released for public use in the USA (2020).

🌐 Professional Memberships

American Neurological Association.Israeli Neuromuscular Society.American Association of Neuromuscular & Electrodiagnostic Medicine

📚 Publications

  • Prolactin and autoimmunity
    Authors: S Shelly, M Boaz, H Orbach
    Year: 2012

 

  • Autonomic dysfunction following COVID-19 infection: an early experience
    Authors: K Shouman, G Vanichkachorn, WP Cheshire, MD Suarez, S Shelly, et al.
    Year: 2021

 

  • Thymoma and autoimmunity
    Authors: S Shelly, N Agmon-Levin, A Altman, Y Shoenfeld
    Year: 2011

 

  • Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy
    Authors: S Shelly, JD Triplett, MV Pinto, M Milone, FE Diehn, A Zekeridou, et al.
    Year: 2020

 

  • Epidemiology and natural history of inclusion body myositis: a 40-year population-based study
    Authors: S Shelly, MM Mielke, J Mandrekar, M Milone, FC Ernste, E Naddaf, et al.
    Year: 2021

 

  • Survival and associated comorbidities in inclusion body myositis
    Authors: E Naddaf, S Shelly, J Mandrekar, AM Chamberlain, EM Hoffman, et al.
    Year: 2022

 

  • Small fiber neuropathy incidence, prevalence, longitudinal impairments, and disability
    Authors: SA Johnson, K Shouman, S Shelly, P Sandroni, SE Berini, PJB Dyck, et al.
    Year: 2021

 

  • Neurochondrin neurological autoimmunity
    Authors: S Shelly, TJ Kryzer, L Komorowski, R Miske, MD Anderson, EP Flanagan, et al.
    Year: 2019

 

  • Potential neurotoxicity of titanium implants: Prospective, in-vivo and in-vitro study
    Authors: S Shelly, SL Zaltsman, O Ben-Gal, A Dayan, I Ganmore, C Shemesh, et al.
    Year: 2021

 

  • Neurofascin-155 immunoglobulin subtypes: clinicopathologic associations and neurologic outcomes
    Authors: S Shelly, CJ Klein, PJB Dyck, P Paul, ML Mauermann, SE Berini, B Howe, et al.
    Year: 2021

 

Conclusion

Dr. Shahar Shelly exemplifies excellence in clinical practice, academic leadership, and innovative research. His focus on using cutting-edge technologies like AI and biomarker discovery aims to transform the diagnosis and treatment of complex neurological and neuromuscular disorders. Driven by a commitment to precision medicine, his career reflects a blend of academic rigor, clinical expertise, and groundbreaking contributions that continue to shape the future of neurology.

 

 

Baoying Huang | Pathogen Biology | Best Researcher Award

Published on by Neuroscientists

Baoying Huang | Pathogen Biology | Best Researcher Award

Ms. Baoying Huang,  National Institute for Viral Disease Control and Prevention, China.

Dr. Baoying Huang, a distinguished professor at the Biotech Center for Viral Disease Emergency, China CDC, has over two decades of experience in combating viral diseases. Her expertise lies in vaccine and antiviral drug development for emerging and re-emerging infectious diseases, including COVID-19, monkeypox, and other human coronaviruses.

 

profile

Scopus

🎓 Education Experience

2008.09–2011.07: Doctor of Medicine, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC.2005.09–2008.07: Master of Biology, Pathogen Biology,Biotech Center for Viral Disease Emergency, China CDC. 2001.09–2005.07: Bachelor of Biology,
Life Science Department, Nan Hua University, China.

👩‍🔬 Professional Experience

2020.07–Present:  Professor, China CD ,Focus: Vaccine and antiviral drug R&D for SARS-CoV-2 and poxvirus diseases, including COVID-19 and monkeypox. Key Role: Participated in COVID-19 Emergency Projects for SARS-CoV-2 variant monitoring in China.2015.07–2020.07:  Associate Professor, China CDC. Focus: Vaccine and antiviral drug R&D for emerging infectious diseases like influenza and coronaviruses (SARS-CoV, MERS-CoV).2015.04–2015.06:  Assistant Professor, China CDC. Global Health Support Program: Worked in Sierra Leone to establish Ebola lab systems, improving public health infrastructure.2011.07–2015.07: Assistant Professor, China CDC. Focus: Pathogenic molecular mechanisms of influenza viruses, pseudo-virus applications, and gene-engineered vaccines. 2005.09–2011.07:  Graduate Researcher, IVDC, China CDC. Specialization: Developing universal influenza vaccines for cross-protection against various strains.

🔬 Research Focus

Baoying Huang’s work is dedicated to:Vaccine Development: COVID-19 vaccines (BBIBP-CorV, mRNA vaccines) and pan-orthopoxvirus solutions.Emerging Diseases: Countermeasures for SARS-CoV-2, monkeypox, and other viral threats.Diagnostics: Whole-genome sequencing and real-time PCR for virus detection and monitoring.Therapeutics: Screening novel antivirals targeting viruses like SARS-CoV-2 and monkeypox.Key achievements include:Leading the development of Sinopharm COVID-19 vaccine, later approved by WHO for Emergency Use Listing.Establishing monitoring systems for SARS-CoV-2 variants and assessing their impact on public health measures. Advancing monkeypox vaccine research and identifying promising antiviral compounds against orthopoxviruses.

📚 Publications

  • Title: Molecular architecture of monkeypox mature virus
    • Authors: Hong, Y., Huang, B., Zhang, J., Tan, W., Li, S.
    • Year: 2024

 

  • Title: Vaccinia virus Tiantan strain blocks host antiviral innate immunity and programmed cell death by disrupting gene expression
    • Authors: Wu, C., Zhang, Z., Li, Z., Deng, Y., Tan, W.
    • Year: 2024

 

  • Title: A clinically used anti-human papilloma virus agent (3-hydroxyphthalic anhydride-modified bovine β-lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus
    • Authors: Sha, Y., Huang, B., Hua, C., Tan, W., Jiang, S.
    • Year: 2024

 

  • Title: Development of a multiplex real-time PCR assay for the simultaneous detection of mpox virus and orthopoxvirus infections
    • Authors: Fan, Z., Xie, Y., Huang, B., Tan, W., Guo, F.
    • Year: 2024

 

  • Title: Accurate determination of the whole genome sequencing and open reading frames composition of non-replicating Tiantan strain of vaccinia virus based on novel long read sequencing platform
    • Authors: Zhang, Z., Wu, C., Li, H., Huang, B., Tan, W.
    • Year: 2024

 

  • Title: Characterization of whole genomes from recently emerging Mpox cases in several regions of China, 2023
    • Authors: Wu, C., Cui, L., Pan, Y., Wang, Q., Tan, W.
    • Year: 2024

 

  • Title: Intranasal immunization with single-dose vaccine based on recombinant influenza virus H1N1 expressing the extracellular domain of respiratory syncytial virus G protein induces robust immunity and protection in mice
    • Authors: Han, R., Wang, D., Wang, T., Huang, B., Tan, W.
    • Year: 2024

 

  • Title: Rapid identification of full-length genome and tracing variations of monkeypox virus in clinical specimens based on mNGS and amplicon sequencing
    • Authors: Wu, C., A, R., Ye, S., Lu, J., Tan, W.
    • Year: 2024

 

  • Title: Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population
    • Authors: Li, M., Guo, Y., Deng, Y., Gao, G.F., Liu, J.
    • Year: 2024

 

  • Title: Identification of the VP37 pocket of monkeypox virus as a promising target for pan-orthopoxvirus inhibitors through virtual screening and antiviral assays
    • Authors: Huo, S., Wu, L., Huang, B., Xu, Z., Tan, W.
    • Year: 2024

 

Conclusion

Dr. Huang’s career exemplifies unwavering dedication to improving public health through innovation in vaccine development, antiviral research, and diagnostic technologies. Her contributions to tackling global health challenges, such as the COVID-19 pandemic and monkeypox outbreaks, have significantly impacted infectious disease prevention and control worldwide. As viruses continue to evolve, her pioneering work remains a cornerstone in safeguarding global health.

 

 

Gustave Mabiama | Epidemiology | Neuroscience Academic Distinction Award

Published on by Neuroscientists

Dr. Gustave Mabiama | Epidemiology | Neuroscience Academic Distinction Award

Dr. Gustave Mabiama, The University of Douala, Cameroon.

Dr. Mabiama Gustave is an accomplished Senior Lecturer-Researcher and Head of Division of University Cooperation at the University of Ebolowa, Cameroon. With dual Ph.D. qualifications in Physiology-Physiopathology and Human Nutrition, he has an extensive academic background, including a Bachelor’s, Postgraduate Diploma, and Master’s degree in applied biology and nutrition. Over a professional career spanning two decades, Dr. Mabiama has contributed significantly to nutrition research, elderly health, HIV/AIDS care, and university education. His expertise extends to clinical training and international collaborations, reflecting his commitment to advancing science and improving community well-being.

 

profile

Scholar

📜 Academic Background

Ph.D.Biology-Health (Physiology-Physiopathology) – University of Limoges, France.Health Sciences (Human Nutrition) – University of Douala, Cameroon. Additional Degrees:Bachelor’s Degree in Applied Biology – University of Ngaoundéré, Cameroon.Postgraduate Diploma in Human Biology – University of Ngaoundéré, Cameroon.Master’s Degree in Food Science and Nutrition – University of Ngaoundéré, Cameroon

🏫 Professional Experience

Current Role:Lecturer-Researcher (Assistant to Senior Lecturer), ENSET Douala (2010–Present).Past Roles:PMTCT, Paediatric HIV, and Nutrition Coordinator – ID-Moundou, Chad / ID-Paris-Poitiers, France (2008–2009)Life and Earth Sciences Teacher & Health Club Supervisor – Protestant College of Ngaoundéré (2000–2008).Instructor, Department of Biological Sciences – Faculty of Science, University of Ngaoundéré (1997–2006).

🛠 Further Training/Internships

2021, Limoges (LINUT): Identifying swallowing disorders. 2020, Limoges (LINUT): Undernutrition in the elderly. 2019, Faculty of Medicine, Limoges: Nutrition in specific conditions (pressure sores, heart failure, palliative care, cancer).2019, Limoges (LINUT): Physical activity recommendations for older adults.2019, University Hospital – Nutrition Unit (Limoges): Internship in Specialized Obesity Care.

🎓 University Courses Attended

2019, Yaoundé: Training Workshop on Scientific Advice for Governments (Nature and Technology Research Fund / INGSA). 2015, Distance Learning: Expertise in Gerontology (University of Montpellier & Pierre and Marie Curie University – Unfinished).2009, Cotonou, Benin: University Course on Food Composition and Biodiversity (BIOVERSITY/FAO). 2007, Abomey-Calavi, Benin: International Training in Nutrition and Food Science (FINSA/FSA/UAC). 2004, Marseille, France: Summer School for Young HIV/AIDS Researchers (AIDES)

📚 Publications

  • Title: Nutritional status and associated factors among community-dwelling elderly
    Authors: G Mabiama, D Adiogo, PM Preux, JC Desport, P Fayemendy, P Jésus
    Year: 2021

 

  • Title: Nutritional status, dementia, and mobility among nursing home’s residents: First exhaustive cross-sectional study in Limousin territory (France)
    Authors: P Fayemendy, G Mabiama, T Vernier, A Massoulard-Gainant, …
    Year: 2021

 

  • Title: Undernutrition, overweight and obesity among elderly living in communities in Africa: a systematic review
    Authors: G Mabiama, D Adiogo, T Millimono, P Fayemendy, T Vernier, …
    Year: 2021

 

  • Title: Undernutrition, overweight and obesity prevalences among community-dwelling elderly in Africa – a systematic review
    Authors: G Mabiama, T Millimono, D Adiogo, F Boumediene, PM Preux, …
    Year: 2022

 

  • Title: Nutritional status and associated factors among the elderly in Guinea: a first national cross-sectional study
    Authors: TM Millimono, A Camara, G Mabiama, M Daffé, F Boumédiène, PM Preux, …
    Year: 2023

 

  • Title: Dénutrition, surpoids et obésité chez les personnes âgées vivant dans des communautés en Afrique: une revue systématique
    Authors: G Mabiama, D Adiogo, T Millimono, F Boumédiène, PM Preux, …
    Year: 2022

 

  • Title: Depressive syndrome, cognitive impairment, and associated factors among community-dwelling aged persons in Cameroon
    Authors: G Mabiama, D Adiogo, PM Preux, JC Desport, P Fayemendy, P Jésus
    Year: 2024

 

  • Title: Undernutrition, socio-demographic characteristics and eating habits of the elderly
    Authors: TM Millimono, A Camara, G Mabiama, F Toure, S Sidibé, PM Preux, …
    Year: 2024

 

  • Title: Analysis of the Feeding Habits and Nutritional Status of Adolescents in Private Non-boarding Secondary Schools in Bamenda II Municipality, Cameroon
    Authors: ENBP Ange, E Manga, G Mabiama, F Evariste
    Year: 2024

 

  • Title: Comparing health students’ attitudes towards dementia, epilepsy and psychiatric disorders: Knowledge, Attitudes and Practices study (KAP) in Low-and Middle-Income countries (LMIC)
    Authors: LC Piver, E Auditeau, M Vergonjeanne, B Calvet, E Ngoungou, …
    Year: 2024

 

Conclusion

Dr. Mabiama Gustave’s career exemplifies excellence in education, research, and public health initiatives. His significant contributions to human nutrition and elderly care are a testament to his dedication to improving lives through science. As a prominent academic and health professional, he continues to foster international partnerships and contribute meaningfully to advancing health sciences, particularly in Africa. His dynamic career serves as an inspiration for integrating research, teaching, and social impact.